Paper37174117
Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.
Zahari S and 2 others. Cancers (Basel), 2023. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression. Papers, record 37174117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37174117
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DIP-2020-002 | National University of Malaysia | PubMed |
Source PubMed
References154
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21825174 | Leukocyte composition of human breast cancer. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/21825174 | PubMed |
| 2 | 35437329 | Breast tumor microenvironment structures are associated with genomic features and clinical outcome. | Nat Genet | 2022 | https://conductscience.org/library/papers/35437329 | PubMed |
| 3 | 32223744 | Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32223744 | PubMed |
| 4 | 25214542 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Ann Oncol | 2015 | https://conductscience.org/library/papers/25214542 | PubMed |
| 5 | 28819126 | Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts. | Sci Rep | 2017 | https://conductscience.org/library/papers/28819126 | PubMed |
| 6 | 34113615 | Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34113615 | PubMed |
| 7 | 28439493 | Targeted therapies in breast cancer: New challenges to fight against resistance. | World J Clin Oncol | 2017 | https://conductscience.org/library/papers/28439493 | PubMed |
| 8 | 11237532 | Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. | Exp Cell Res | 2001 | https://conductscience.org/library/papers/11237532 | PubMed |
| 9 | 27107051 | The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. | J Natl Cancer Inst | 2016 | https://conductscience.org/library/papers/27107051 | PubMed |
| 10 | 29872722 | Organotropism: new insights into molecular mechanisms of breast cancer metastasis. | NPJ Precis Oncol | 2018 | https://conductscience.org/library/papers/29872722 | PubMed |
| 11 | 27402610 | An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes. | Am J Clin Pathol | 2016 | https://conductscience.org/library/papers/27402610 | PubMed |
| 12 | 29394917 | Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29394917 | PubMed |
| 13 | 22815141 | Breast cancer survival in the US and Europe: a CONCORD high-resolution study. | Int J Cancer | 2013 | https://conductscience.org/library/papers/22815141 | PubMed |
| 14 | 30465162 | Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. | Cancer Metastasis Rev | 2018 | https://conductscience.org/library/papers/30465162 | PubMed |
| 15 | 27669436 | Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis. | Oncogene | 2017 | https://conductscience.org/library/papers/27669436 | PubMed |
| 16 | 31539656 | Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo. | Acta Biomater | 2019 | https://conductscience.org/library/papers/31539656 | PubMed |
| 17 | 35396508 | PARP inhibition in breast cancer: progress made and future hopes. | NPJ Breast Cancer | 2022 | https://conductscience.org/library/papers/35396508 | PubMed |
| 18 | 22763439 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. | Nature | 2012 | https://conductscience.org/library/papers/22763439 | PubMed |
| 19 | 28044258 | Tumor vascular infarction: prospects and challenges. | Int J Hematol | 2017 | https://conductscience.org/library/papers/28044258 | PubMed |
| 20 | 34433812 | Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study. | NPJ Breast Cancer | 2021 | https://conductscience.org/library/papers/34433812 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882231 | Stemness-Associated Biomarkers in Breast Cancer Liver Metastasis: Hepatic Adaptation, Prognostic Relevance, and Monitoring. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42882231 | PubMed |
| 42670211 | Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple-Negative Breast Tumours. | Anal Cell Pathol (Amst) | 2026 | https://conductscience.org/library/papers/42670211 | PubMed |
| 42384634 | Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression. | PLoS One | 2026 | https://conductscience.org/library/papers/42384634 | PubMed |
| 42036011 | Notch signaling regulates the secretion of pro-metastatic factors in extracellular vesicles in liposarcoma. | Cancer Lett | 2026 | https://conductscience.org/library/papers/42036011 | PubMed |
| 41794909 | A CAM bioimaging model reveals the connection between VEGFA vascular remodeling and enhanced sarcoma progression via tumor secretome. | Sci Rep | 2026 | https://conductscience.org/library/papers/41794909 | PubMed |
| 40928878 | Replication stress-induced nuclear hypertrophy alters chromatin topology and impacts cancer cell fitness. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40928878 | PubMed |
| 40612872 | Clinically proven natural products against breast cancer, with mechanistic insights. | Oncol Res | 2025 | https://conductscience.org/library/papers/40612872 | PubMed |
| 40422206 | 17β-Estradiol Promotes Tumorigenicity Through an Autocrine AREG/EGFR Loop in ER-α-Positive Breast Cancer Cells. | Cells | 2025 | https://conductscience.org/library/papers/40422206 | PubMed |
| 40361968 | Advanced Deep Learning Approaches in Detection Technologies for Comprehensive Breast Cancer Assessment Based on WSIs: A Systematic Literature Review. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40361968 | PubMed |
| 39891260 | Detection of breast cancer lesions using APT weighted MRI: a systematic review. | J Transl Med | 2025 | https://conductscience.org/library/papers/39891260 | PubMed |
| 39789641 | Secreted LGALS3BP facilitates distant metastasis of breast cancer. | Breast Cancer Res | 2025 | https://conductscience.org/library/papers/39789641 | PubMed |
| 38594742 | Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/38594742 | PubMed |
| 38001652 | Updates on Breast Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38001652 | PubMed |
| 37686233 | Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686233 | PubMed |
Genes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37174117
GET https://conductscience.org/api/papers/v1/37174117/references?page=2